Richard Daly
Directeur Général chez CATALYST PHARMACEUTICALS, INC.
Fortune : 3 M $ au 30/04/2024
Postes actifs de Richard Daly
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 19/02/2015 | - |
| Directeur Général | 01/01/2024 | - | |
| President | 01/01/2024 | - | |
| Independent Dir/Board Member | 19/02/2015 | 01/01/2024 | |
| Corporate Officer/Principal | 28/05/2015 | 18/08/2015 | |
| Andean Health & Development | Directeur/Membre du Conseil | - | - |
Historique de carrière de Richard Daly
Anciens postes connus de Richard Daly
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
CARsgen Therapeutics Corp
 CARsgen Therapeutics Corp BiotechnologyHealth Technology CARsgen Therapeutics Corp is based in San Diego, CA. Part of CARsgen Therapeutics Holdings Ltd., CARsgen Therapeutics Corp is a biopharmaceutical company focused on innovative car t-cell therapies for the treatment of hematologic malignancies and solid tumors. The company has built an integrated cell therapy platform with in-house capabilities that span target discovery, antibody development, clinical trials, and commercial-scale manufacturing. | President | 17/01/2022 | 01/05/2023 |
| OPIANT PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 12/06/2018 | 02/03/2023 |
| Independent Dir/Board Member | 12/06/2018 | 02/03/2023 | |
| BEYONDSPRING INC. | Directeur des opérations | 01/07/2018 | 01/01/2022 |
BeyondSpring Pharmaceuticals, Inc.
 BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Directeur des opérations | 01/07/2018 | 01/01/2022 |
| PALISADE BIO, INC. | Comptroller/Controller/Auditor | 30/04/2017 | 06/08/2018 |
| Directeur Général | 15/02/2016 | 06/08/2018 | |
| Président | 13/06/2016 | 06/08/2018 | |
| Directeur Financier/CFO | 30/04/2017 | 06/08/2018 | |
| President | 15/02/2016 | 06/08/2018 | |
| SYNERGY PHARMACEUTICALS INC | Directeur/Membre du Conseil | 30/06/2015 | 01/06/2018 |
| Independent Dir/Board Member | 30/06/2015 | 01/06/2018 | |
| Ravine Rock Partners LLC | Corporate Officer/Principal | 01/10/2014 | 01/09/2016 |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░ ░░░░░░░░░ | - | - | |
| ░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Richard Daly
| University of Notre Dame | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 16 |
Opérationnelle
| Corporate Officer/Principal | 5 |
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
Sectorielle
| Health Technology | 11 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| BEYONDSPRING INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. | Health Technology |
| Andean Health & Development | |
TAP Pharmaceutical Products, Inc.
 TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
| Sagepath Partners LLC | |
| Ravine Rock Partners LLC | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
CARsgen Therapeutics Corp
CARsgen Therapeutics Corp BiotechnologyHealth Technology CARsgen Therapeutics Corp is based in San Diego, CA. Part of CARsgen Therapeutics Holdings Ltd., CARsgen Therapeutics Corp is a biopharmaceutical company focused on innovative car t-cell therapies for the treatment of hematologic malignancies and solid tumors. The company has built an integrated cell therapy platform with in-house capabilities that span target discovery, antibody development, clinical trials, and commercial-scale manufacturing. | Health Technology |
BeyondSpring Pharmaceuticals, Inc.
BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Health Technology |
- Bourse
- Insiders
- Richard Daly
- Expérience
